Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus

• Published in: Phytomedicine (Stuttgart) Vol. 15; no. 12; pp. 1108 - 1116
• Main Authors: Schnitzler, P., Schneider, S., Stintzing, F.C., Carle, R., Reichling, J.
• Format: Journal Article
• Language: English
• Published: Germany Elsevier GmbH 01.12.2008; Urban & Fischer Verlag
• Subjects: Animals; Antiviral activity; Antiviral Agents - analysis; Antiviral Agents - pharmacology; Aqueous extract; Cell Survival; Cells, Cultured; Cercopithecus aethiops; Chemical properties; Chromatography, High Pressure Liquid; Control; Geraniums; Health aspects; Herpes; Herpes simplex virus; Herpesvirus 1, Human - drug effects; Herpesvirus 1, Human - physiology; Herpesvirus 2, Human - drug effects; Herpesvirus 2, Human - physiology; Herpesvirus diseases; Mass Spectrometry; Materia medica, Vegetable; Pelargonium - chemistry; Pelargonium sidoides; Plant extracts; Plant Extracts - chemistry; Plant Extracts - pharmacology; Viral Plaque Assay; Virus Replication - drug effects; Germany; Aqueous extract; Pelargonium sidoides; Herpes simplex virus; Antiviral activity
• ISSN: 0944-7113; 1618-095X
• DOI: 10.1016/j.phymed.2008.06.009

The compounds of an aqueous root extract of the African medicinal plant Pelargonium sidoides were analysed by LC–MS spectroscopy and the antiviral effect of this extract against herpes simplex virus was examined in cell culture. Besides predominant coumarins, simple phenolic structures as well as flavonoid and catechin derivatives were identified as major constituents in the Pelargonium extract. The inhibitory activity of this extract against herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) was tested in vitro on RC-37 cells using a plaque reduction assay and exhibited high antiviral activity against both herpesviruses in viral suspension tests. The 50% inhibitory concentration (IC 50) of the aqueous Pelargonium sidoides extract for herpes simplex virus plaque formation was determined at 0.00006% and 0.000005% for HSV-1 and HSV-2, respectively. At maximum noncytotoxic concentrations of the extract, plaque formation was significantly reduced by more than 99.9% for HSV-1 and HSV-2 and a clear concentration-dependent antiviral activity against HSV could be demonstrated for this extract. In order to determine the mode of antiviral action, the extract was added at different times to the cells or viruses during the infection cycle. Both herpesviruses were significantly inhibited when pretreated with the plant extract or when the extract was added during the adsorption phase, whereas acyclovir demonstrated antiviral activity only intracellularly during replication of HSV. These results indicate that P. sidoides extract affected the virus before penetration into the host cell and reveals a different mode of action when compared to the classical drug acyclovir. Hence this extract is capable of exerting an antiviral effect on herpes simplex virus and might be suitable for topical therapeutic use as antiviral drug both in labial and genital herpes infection.